Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Assets Average (2016 - 2025)

Historic Assets Average for Iovance Biotherapeutics (IOVA) over the last 12 years, with Q3 2025 value amounting to $906.2 million.

  • Iovance Biotherapeutics' Assets Average changed N/A to $906.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $906.2 million, marking a year-over-year change of. This contributed to the annual value of $845.4 million for FY2024, which is N/A changed from last year.
  • Iovance Biotherapeutics' Assets Average amounted to $906.2 million in Q3 2025.
  • Iovance Biotherapeutics' 5-year Assets Average high stood at $938.6 million for Q1 2025, and its period low was $610.3 million during Q1 2023.
  • In the last 3 years, Iovance Biotherapeutics' Assets Average had a median value of $820.7 million in 2023 and averaged $828.7 million.
  • Its Assets Average has fluctuated over the past 5 years, first soared by 3520.39% in 2024, then skyrocketed by 1375.52% in 2025.
  • Iovance Biotherapeutics' Assets Average (Quarter) stood at $816.3 million in 2023, then increased by 1.07% to $825.1 million in 2024, then increased by 9.83% to $906.2 million in 2025.
  • Its last three reported values are $906.2 million in Q3 2025, $937.1 million for Q2 2025, and $938.6 million during Q1 2025.